Top news

View all

Gavi and UNICEF welcome approval of new oral cholera vaccine

Gavi, the Vaccine Alliance and UNICEF welcome the news that a new oral cholera vaccine (OCV), Euvichol-S, has now received WHO prequalification and can be made available to countries around the world.

Brazilian Ministry of Health and Gavi reaffirm partnership to advance equitable immunisation globally

The Brazilian Ministry of Health (MoH) and Gavi, the Vaccine Alliance, have signed a landmark Memorandum of Understanding (MoU) to collaborate on vaccine production, innovation, and global access.

Global deployment of rapid diagnostic tests to boost fight against cholera

More than 1.2 million cholera rapid diagnostic tests will be shipped to 14 countries in largest-ever global deployment, with the first shipment landing today in Malawi.

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Visit page

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Visit page

Top VaccinesWork stories

View all stories

Gavi CEO Sania Nishtar reflects on her recent visit to Central African Republic and Nigeria

Gavi’s CEO discusses the importance of putting the countries that Gavi supports at the heart of everything the organisation does, and reflects on lessons and key outcomes from her recent trips to Central African Republic and Nigeria.

Bird flu in cattle: What are the concerns surrounding the newly emerging bovine H5N1 influenza virus?

Bird flu in U.S. dairy cows has Canadian public health experts on high alert. With one human case identified in Texas, what is the likelihood of H5N1 influenza moving from birds to mammals to people?

The number of children in a family can influence access to vaccines

New research suggests the number of siblings in a family is a factor in determining whether or not children receive any essential immunisations.

Vaccines support

Gavi supports vaccines against 19 infectious diseases, including, most recently, COVID-19, Ebola and malaria. Learn more about our support for each vaccine by clicking below.

Visit page

Gavi supports vaccines against 19 infectious diseases, including, most recently, COVID-19, Ebola and malaria. Learn more about our support for each vaccine by clicking below.

Visit page

Our impact

Children >1 billion children vaccinated through routine programmes
First aid locator >17.3 million future deaths averted
Transitioned 19 countries fully self-financing
Billions >220.5 US$ billion in economic benefits for countries
Syringe 1.8 billion vaccinations through preventive vaccination campaigns

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter